Neuromodulation is conducted with a device that uses electrical currents or magnets to adjust or change activity that occurs in the brain. Some of these devices can stop attacks that are already underway, while others are used preventatively. Similar to how a cardiac pacemaker corrects abnormal heartbeats, neuromodulation therapies help re-establish the normal function of the nervous system. Thus, neuromodulation modalities are considered as a promising alternative when existing treatment becomes problematic for long-term use due to the development of tolerance, addiction, and adverse side effects. These minimally invasive procedures have tremendous potential to improve patients’ lives.
Europe accounted for the second-largest share of the market in 2018. A well-developed healthcare infrastructure, coupled with growing approvals for non-invasive devices in the region, is fueling the demand for these devices. New entrants and regional players have received CE mark approvals for their devices during 2017-2018. This is anticipated to bolster the market’s growth in Europe in the next couple of years. Since multiple hospitals and clinics are already offering treatments based on brain stimulation, a wide variety of medical companies has started entering the market with their own latest and greatest neuromodulation devices. To help organisations navigate through the best-of-breed neuromodulation devices, MedTech Outlook has compiled a list of ‘Top 10 Neuromodulation Solutions Providers in Europe – 2022.’ Along with the enlisted organisations offering innovative brain health and brain enhancement systems, the magazine also comprises insights from thought leaders on industry trends, best practices, recent innovations, and their advice for aspiring CIOs.
We present to you MedTech Outlook’s “Top 10 Neuromodulation Solutions Providers in Europe – 2022.”
